Uquifa is a renowned brand in the pharmaceutical and animal health industries, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. With 86 years of experience, Uquifa has built a solid reputation based on its commitment to quality and reliable service. The company operates two manufacturing sites, one in Spain and another in Mexico, both adhering to strict regulatory norms and operating under cGMP conditions.

These sites have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the US FDA. Uquifa's services also extend to the Contract Development and Manufacturing Organization (CDMO) sector through its subsidiary, Soneas. With three locations in Budapest, Soneas offers route scouting, process optimization, small-scale cGMP manufacturing, and large-scale non-GMP manufacturing.

With a global customer base spanning over 70 countries, Uquifa caters to major generic and ethical companies. The company boasts an impressive portfolio of over 150 active DMFs filed and 20 CEPs approved, reflecting its dedication to research and innovation. Uquifa continues to invest in personnel, facilities, and processes to stay at the forefront of technological advancements, ensuring it remains a trusted partner in the pharmaceutical and animal health industries